Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19

This commentary describes racial disparities in access to medication assisted treatment (MAT) for opioid use disorder (OUD) and how pandemic-related changes in access to MAT may exacerbate these disparities. The author also provides specific recommendations, including actions that can be taken by local health departments to reduce race-based inequities in access to MAT during the pandemic.

Resource Details

• Population: Black or African American|Hispanic, Latino, or Latinx|People With Substance Use Disorders
• Topics of Practice: Policy Change/ Development
• Outcomes of Interest: Advancing Racial Equity|Reduction of Health Disparities
• Level of Evidence: Novel
• Tools or Materials Included in Resource: No
• Social Determinants of Health: Healthcare Access and Quality|Social and Community Context
• Outside of US: No